Dynavax Technologies
DVAX
$11.80
Share price
4.06%
Change (1 day)
7.27%
Change (1 year)
Categories
Number of shares outstanding for Dynavax Technologies (DVAX)
Number of shares outstanding as of April 2024 : 128,988,000
According to Dynavax Technologies 's latest financial reports and stock price the company's current number of shares outstanding is 128,988,000. At the end of 2023 the company had 128,988,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Dynavax Technologies from 2014 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.12 B | 1.1% |
| 2022 | 0.12 B | 5.12% |
| 2021 | 0.12 B | 10.17% |
| 2020 | 0.11 B | 31.37% |
| 2019 | 83.86 M | 33.77% |
| 2018 | 62.69 M | 2.77% |
| 2017 | 61 M | 58.28% |
| 2016 | 38.54 M | 0.3% |
| 2015 | 38.42 M | 46.13% |
| 2014 | 26.29 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 4,277.93% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 314.77% | 🇺🇸 USA |
 Biogen BIIB | 144,800,000 | 12.26% | 🇺🇸 USA |
 Gilead Sciences GILD | 1,248,000,000 | 867.53% | 🇺🇸 USA |
 Merck MRK | 2,554,166,667 | 1,880.16% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 2,301.77% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2,028,000,000 | 1,472.24% | 🇬🇧 UK |
 Agenus
AGEN | 378,152,000 | 193.17% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 769.07% | 🇮🇱 Israel |